Four drugs approved by the FDA since Oct. 3:
- Reyvow is Eli Lilly's second migraine drug approved this year. It is a complementary therapy to the drugmakers other migraine drug, Emgality, and was shown to relieve migraine symptoms within two hours.
- Scenesse is an implant that goes under the skin. It is the first FDA-approved treatment for erythropoietic protoporphyria, a rare skin disorder that causes pain when exposed to sunlight.
- Fasenra, AstraZenaca's asthma drug that was originally approved in 2017, received approval to be self-administered. It comes as a prefilled, single-use autoinjector and is now the third respiratory biologic with the option to be self-administered.
- Descovy is the second drug approved to prevent HIV. It is a daily pre-exposure prophylaxis treatment that caused controversy because it wasn't approved for women.